Wu, Yuejin
Wang, Qinchuan
Feng, Ning
Granger, Jonathan M.
Anderson, Mark E.
Funding for this research was provided by:
NIH
NIH
Article History
Received: 21 January 2019
Accepted: 11 June 2019
First Online: 26 June 2019
Competing Interests
: M.E. Anderson is a cofounder of Allosteros Therapeutics, a biotech company developing CaMKII inhibitor drugs to treat cardiovascular disease.